CHANGED BY CANCER

Cancer doesn't just change your health; it changes your world. *CHANGED BY CANCER* shares raw, lived experiences at the intersection of personal healing and systemic change. We amplify the voices of those rewriting their narratives and navigating the challenges of a diagnosis with honesty, insight, and community.

CHANGED BY CANCER is a health podcast hosted by Randi Paynter, with 14 episodes on record and a Required Pod Score of 80. PitchCentric scores this show on Booking Probability, Listen Score, and live audience signals refreshed every 24 hours.

Randi Paynter hosts CHANGED BY CANCER, a health show with 14 episodes published.

Our AI reads these to draft pitches. Use them as grounding for a pitch that cites a real guest and a specific topic.

• 

  Episode #14

  “Changed by Caregiving: The Hidden Backbone of Cancer Care” — Charlotte Bayala

  Aug 19, 20261h 1m

  When someone receives a cancer diagnosis, the impact is never confined to the individual patient. It sends an immediate shockwave through an entire family, transforming spouses, partners, parents, and children overnight into primary advocates, home clinicians, and logistical anchors. In this episode of Changed By Cancer, host Dr. Randi Paynter sits down with Charlotte Bayala, host of The Cancer Caregiver and Caregiver Breathing Room. For nearly fourteen years, Charlotte has walked beside her husband through an aggressive, incurable variant of papillary thyroid cancer — navigating nine surgeries, major anatomical complications, and repeated relocations between academic cancer centers. Charlotte pulls back the curtain on the invisible labor of informal caregiving, how our medical infrastructure takes family care for granted, and what it truly looks like to establish boundaries, protect your children, and reclaim your own identity and nervous system. In This Episode: • The Ecosystem of Cancer • Diagnosis Day: Facing Tall Cell Variant Thyroid Cancer • The Epi Edit: Aggressive Histologies & Radioactive Iodine Resistance • 14 Years, 9 Surgeries & The Persistence of Patient Advocacy • Creating Family Containers: Shielding Children & Gatekeeping • The Epi Edit: Psychoneuroimmunology & The Physical Toll of Caregiving • Founding The Cancer Caregiver & Moving Beyond Empty Catchphrases • The Epi Edit: The $600 Billion Economic Reality of Unpaid Care • Immediate Clinical Reforms: How Healthcare Can Support Caregivers Connect with Charlotte Bayala: • Website: https://www.charlottebayala.com/ • Listen to The Cancer Caregiver: https://www.cancercaregiverpodcast.com • Listen to Caregiver Breathing Room: https://www.charlottebayala.com/caregiver-breathing-room • Connect with Charlotte on Instagram: https://www.instagram.com/cancercaregiverpodcast/ • Connect with Charlotte on YouTube: https://www.youtube.com/@cancercaregiver • Connect with Charlotte on LinkedIn: https://www.linkedin.com/in/charlottebayala/ Resources: 1. Caregiver Advocacy & Practical Support • Family Caregiver Alliance (FCA) / National Center on Caregiving https://www.caregiver.org/ Offers state-by-state caregiver resource locators, practical skill sheets (e.g., wound care and managing medications at home), and webinars focused on family dynamics and boundary setting. • Cancer Support Community (CSC) – Caregiver Helpline & Registry https://www.cancersupportcommunity.org/ Provides a dedicated, toll-free helpline (888-793-9355) staffed by oncology social workers, alongside free virtual support groups specifically for family caregivers. • Triage Cancer – Caregiver Legal & Financial Toolkit https://triagecancer.org/ A national nonprofit offering practical guides on navigating employment rights (FMLA, ADA accommodations), disability insurance, medical leave, and healthcare appeals for caregivers. 2. Disease-Specific Clinical Resources (Thyroid Cancer) • ThyCa: Thyroid Cancer Survivors’ Association https://thyca.org/ A global non-profit providing support groups, education, and specialist-reviewed materials specifically covering advanced, persistent, and radioactive iodine-refractory thyroid cancer variants. • American Thyroid Association (ATA) – Clinical Management Guidelines https://www.thyroid.org/ Publicly accessible patient and family education brochures detailing the behavior, monitoring pathways, and targeted therapies for aggressive thyroid histologies. 3. Epidemiologic Research, Health Policy & Economics • AARP Public Policy Institute – Valuing the Invaluable Report Series https://www.aarp.org/pri/departments/ppi/ The landmark economic analysis mapping the $600 billion national economic contribution and out-of-pocket costs borne by informal family caregivers. • National Cancer Institute (NCI) – Informal Caregivers in Cancer Care (PDQ®) https://www.cancer.gov/about-cancer/coping/family-friends/family-caregivers-pdq Comprehensive, evidence-based clinical summaries reviewing the psychoneuroimmunology, distress prevalence, and biological morbidity associated with oncology caregiving. • Memorial Sloan Kettering (MSK) – Talking with Children About Cancer Program https://www.mskcc.org/experience/patient-support/counseling/talking-with-children Clinical guidelines and parenting resources designed to help families navigate boundaries, communication, and age-appropriate support when a parent is living with cancer. For More Information: • Full clinical citations, research references, and transcripts: https://ChangedByCancer.com • Watch full video episodes on YouTube: https://www.youtube.com/@ChangedByCancer Disclaimer: Dr. Randi Paynter is a cancer epidemiologist, not a medical clinician. Conversations on this show explore personal experiences and systemic issues in healthcare; they are not intended as individual medical advice. Consult your personal care team for all health-related decisions.

  ListenShow Notes
• 

  Episode #13

  "The Reset" (Marissa — Part 2)

  Aug 12, 202650 min

  "So to me, the chemo was a healing experience. I felt good from it." — Marissa In Part One, Marissa described a decade-long path through progressive Multiple Sclerosis and an aggressive Stage III breast cancer diagnosis that arrived, paradoxically, as a second chance at life. In Part Two, host Dr. Randi Paynter continues the conversation as Marissa begins the chemotherapy regimen designed to treat her cancer — and instead finds that it starts undoing years of neurological damage. Marissa opens by describing what it's actually like to navigate specialty medication costs and insurance approval, even with pharmacist training and a physician husband in her corner — a candid look at how little clinical fluency protects patients from a system built around cost containment. As she moves through her ACT chemotherapy regimen, Marissa and Dr. Paynter trace an unexpected biological overlap: two of the chemo drugs prescribed for her cancer appear to have halted her multiple sclerosis in its tracks. This episode's Epi Edit breaks down the emerging science of Immune Reconstitution Therapy (IRT) — the paradigm reshaping how neurologists think about durable MS remission. Marissa also walks through the surprisingly complex logistics of cold capping to preserve her hair during chemo, and reveals a hereditary ATM gene mutation that shaped both her diagnosis and her family's future cancer screening. The episode traces her long, nonlinear recovery — from a single Taxotere dose that set her MS back overnight, to relearning to walk, to driving independently for the first time in years. Correction & Clarification: At approximately 13 minutes into this conversation, Marissa references doxorubicin and cyclophosphamide as having been used clinically to treat aggressive multiple sclerosis. Cyclophosphamide does have documented clinical use in aggressive MS (see research below). Doxorubicin's disease-modifying effects on MS-like disease, however, have so far been demonstrated in animal models only — it is not an established clinical treatment for MS in humans. We're noting this correction for accuracy, and thank Marissa for catching and clarifying it after we spoke. In this episode, we discuss: The Specialty Medication Trap: Why pharmacological training and even a physician spouse can't shield patients from insurance-driven drug pricing and access barriers. A Chemo-Induced MS Remission: How two of the chemotherapy drugs used to treat Marissa's breast cancer appear to have halted her multiple sclerosis — and the emerging science of Immune Reconstitution Therapy (IRT). Cold Capping, Demystified: The dry ice, timing, and cost logistics behind scalp cooling to prevent hair loss during chemo — and why access to it shouldn't be limited to those who can afford it. The ATM Gene: A hereditary risk factor beyond BRCA1/BRCA2, and what a moderate-penetrance mutation means for lifetime breast and pancreatic cancer risk. A Long, Nonlinear Recovery: Physical therapy, a serious MS flare triggered by a single chemo dose, and the slow return of mobility and independence — including driving again. Becoming Your Own Medical Archivist: What happens when your entire care team turns over, and why documenting your own history is essential. Go to ChangedByCancer.com for show notes, research citations, and resource links. Research articles & links referenced: Immune Reconstitution Therapy Overview: Lünemann JD, Ruck T, Muraro PA, Bar-Or A, Wiendl H. Immune reconstitution therapies: concepts for durable remission in multiple sclerosis. Nat Rev Neurol. 2020 Jan;16(1):56-62. doi: 10.1038/s41582-019-0268-z. Epub 2019 Oct 24. Scalp Cooling Therapy: Kaufman L, Valentic L, Malley L, Icksarus C, Rose L, Dulmage B. Scalp cooling therapy in chemotherapy-induced alopecia: addressing variability in cooling duration and efficacy. Support Care Cancer. 2025 Nov 1;33(11):1005. doi: 10.1007/s00520-025-10058-y. PMID: 41174233; PMCID: PMC12578718. Cold Caps & Scalp Cooling — General Overview: Breastcancer.org, "Cold Caps and Scalp Cooling Systems." https://www.breastcancer.org/treatment-side-effects/hair-loss/cold-caps-scalp-cooling The ATM Gene & Breast Cancer: Stucci LS, Internò V, Tucci M, Perrone M, Mannavola F, Palmirotta R, Porta C. The ATM Gene in Breast Cancer: Its Relevance in Clinical Practice. Genes (Basel). 2021 May 13;12(5):727. doi: 10.3390/genes12050727. PMID: 34068084; PMCID: PMC8152746. Chemotherapy & MS — Clinical Case Series: Santos-García D, Prieto JM, Lema M. Clinical course of multiple sclerosis in patients treated with cytostatic drugs for cancer. Rev Neurol. 2009 Jan 16-31;48(2):71-4. Spanish. PMID: 19173204. Chemotherapy & MS — Exacerbation Case Report: Rust H, Kuhle J, Kappos L, Derfuss T. Severe exacerbation of relapsing-remitting multiple sclerosis after G-CSF therapy. Neurol Neuroimmunol Neuroinflamm. 2016 Mar 9;3(2):e215. doi: 10.1212/NXI.0000000000000215. PMID: 27027097; PMCID: PMC4794809. MS Treatment Research: Shimizu K, Agata K, Takasugi S, Goto S, Narita Y, Asai T, Magata Y, Oku N. New strategy for MS treatment with autoantigen-modified liposomes and their therapeutic effect. J Control Release. 2021 Jul 10;335:389-397. doi: 10.1016/j.jconrel.2021.05.027. Epub 2021 May 24. PMID: 34033858. Related listening: Rachel's episode ("The No-Bull Truth") for more on staying organized as your own medical advocate. Changed By Cancer is hosted by Dr. Randi Paynter, a cancer epidemiologist. This podcast shares personal experiences and systemic issues in healthcare. It is not medical advice. Please consult your own medical team for health-related decisions.

  ListenShow Notes
• 

  Episode #12

  "MS — At Least It's Not Cancer" (Marissa — Part 1)

  Aug 5, 202654 min

  "When I got diagnosed with breast cancer, all of a sudden I realized I could die. And then I felt terrible about how little I thought of my life and realized that I actually had a wonderful life... Being alive meant I could see my family, read a book, go outside. I could not believe how much I didn't see that I had all along." — Marissa In 2012, Marissa was a 42-year-old mother living in South Florida when she experienced a severe, sudden, and inexplicable major depressive episode. It would take years — and a series of subtle physical disconnects — to learn that this psychological shift was actually the initial onset of progressive Multiple Sclerosis. In Part 1 of this special two-part feature, host Dr. Randi Paynter sits down with Marissa to trace a decade-long journey through neuroinflammatory disease, progressive mobility shifts, systemic insurance step therapy, and the psychological weight of chronic isolation. Note on Clinical Background: Marissa trained and previously worked as a licensed pharmacist. While she is not currently practicing, her educational background naturally informed how she understood her treatments and parsed complex drug interactions. We highlight this background not to set an expectation, but to emphasize the exact opposite: navigating complex diagnoses, insurance bureaucracy, and drug protocols is daunting for anyone , and patients without a medical or science background should never feel intimidated or place unreasonable expectations on themselves to master these systems alone. When a routine mammogram revealed aggressive Stage 3 breast cancer, Marissa experienced a reaction her oncologist never expected: pure gratitude for a second chance to fight for her life. We also feature another installment of The Epi Edit , where Dr. Paynter steps outside the interview to analyze the neuroepidemiology of the MS prodrome and the structural mechanisms behind insurance step therapy. In this episode, we discuss: The MS Prodrome: Why severe psychiatric and cognitive shifts frequently precede motor impairment in neuroinflammatory conditions. Diagnostic Misdirection: Bouncing between specialists, joint hypermobility, and the fear of hereditary neurological conditions. The Emotional Toll of Mobility Devices: Navigating the psychological boundary from walking poles to full-time wheelchair reliance. The Insurance Step Therapy Trap: How cost-containment protocols force patients to "fail" older, less effective drugs before approving advanced therapies. The Power of Public Advocacy: How a single social media comment bypassed a months-long insurance wall to secure second-year chemotherapy coverage for MS. A Surreal Perspective Shift: Why hearing a Stage 3 breast cancer diagnosis felt like an immediate lifeline after years of progressive disability. Go to ChangedByCancer.com for show notes, research citations, and resource links. Research articles & links referenced: Understanding the MS Prodrome: Makhani N, Tremlett H. The multiple sclerosis prodrome. Nat Rev Neurol. 2021 Aug;17(8):515-521. doi: 10.1038/s41582-021-00519-3. Epub 2021 Jun 21. PMID: 34155379; PMCID: PMC8324569. Insurance Step Therapy & Access: Mizell R. The Impact of Insurance Restrictions in Newly Diagnosed Individuals With Multiple Sclerosis. Int J MS Care. 2024 Jan-Feb;26(1):17-21. doi: 10.7224/1537-2073.2022-069. Epub 2024 Jan 5. PMID: 38213675; PMCID: PMC10779716. Breast Cancer Staging & Curative Intent: National Cancer Institute (NCI) Comprehensive Overview on Stage III Estrogen Receptor-Positive Breast Cancer. https://www.cancer.gov/types/breast/stages Changed By Cancer is hosted by Dr. Randi Paynter, a cancer epidemiologist. This podcast shares personal experiences and systemic issues in healthcare. It is not medical advice. Please consult your own medical team for health-related decisions.

  ListenShow Notes
• 

  Episode #11

  "The Elite Runner of Survivors" (Deborah — Part 2)

  Jul 22, 202651 min

  "Every day that I wake up and I don't have a new tumor, I'm adding to the survivorship data. So you have to live with a certain amount of uncertainty... I would like to curl up at night with a whole sheaf of data that doesn't exist yet, because I'm the one who's helping to create it." — Deborah When we evaluate health metrics on a macro scale, we often treat long-term oncology survivorship as a finished equation — a simple box checked after a patient rings a bell. But the actual infrastructure of survival is far more complex, held together by human relationships, psychological boundaries, and systemic privileges. In the conclusion of this special two-part feature, titled "The Elite Runner of Survivors," host Dr. Randi Paynter sits down with health sciences librarian Deborah to document the raw, unfiltered realities of long-term, advanced survivorship. After severe eye toxicities forced her to discontinue her dual combination targeted therapies (Tafinlar + Mekinist) in February 2020, Deborah walked off the edge of established clinical guidelines to navigate life as a true biological outlier. In this episode, we move past the clinical trials to explore how families establish boundaries in a crisis, how we navigate profound grief and loss within a medical space, and how Deborah pivoted her entire career to train the next generation of healthcare providers. We discuss: Parenting in a Crisis: The deliberate strategies Deborah used to protect her young sons from a climate of fear. The Epi Edit: The molecular science of V600 BRAF/MEK dual pathway inhibition and why combining toxic agents can paradoxically balance out specific side effects. The Phlebotomy Desk Bond: A tribute to Bakari, a nursing student from the Gambia whose tragic loss deeply impacted Deborah's care journey. The Career Transformation: How Deborah transitioned into academic health sciences librarianship, teaching medical and nursing students how to navigate evidence-based practice. Delivering Bad News: Reflecting on teaching medical students and the raw memory of finding out about her own diagnosis over the phone. The "Elite Runner" Deficit: What it actually feels like to cope with PTSD, survivor's guilt, and "scanxiety" when your clinic graduates you to annual MRIs. -- Go to ChangedByCancer.com for show notes, resources, and links to Deborah's blog I'll Live Resources mentioned: BRAF and MEK Pathway Inhibition: Subbiah V, Baik C, Kirkwood JM. Clinical Development of BRAF plus MEK Inhibitor Combinations. Trends Cancer. 2020 Sep;6(9):797-810. doi: 10.1016/j.trecan.2020.05.009. Epub 2020 Jun 13. PMID: 32540454. https://www.sciencedirect.com/science/article/pii/S2405803320301643 The Breakthrough Documentary: https://www.uncommonproductions.com/breakthrough Deborah's Blog: I'll Live https://ill-live.com/ Changed By Cancer is hosted by Dr. Randi Paynter, a cancer epidemiologist. This podcast shares personal experiences and systemic issues in healthcare. It is not medical advice. Please consult your own medical team for health-related decisions.

  ListenShow Notes
• 

  Episode #10

  Alice in Wonderland Meets Sci-Fi (Deborah — Part 1)

  Jul 15, 202635 min

  In April of 2013, Deborah was a busy mother of two young boys living in Brooklyn when a spot on her back came back positive for malignant melanoma. A sentinel lymph node biopsy was clear, but the pathology noted "melanoma in transit" — malignant cells already on their way to other parts of her body. By September of 2014, the "bad stuff" had landed in her lungs. Her oncologist recommended a clinical trial combining a short course of radiation with a novel immunotherapy drug named Ipilimumab (Yervoy). But after just two infusions, Deborah developed severe, life-threatening colitis, forcing her team to halt the therapy entirely. Then came the spring of 2015. Just days after being told her lungs showed No Evidence of Disease, Deborah woke up and realized she couldn't find the words to speak. An emergency MRI revealed nine active brain tumors. In this first part of a special two-part feature, host Dr. Randi Paynter sits down with Deborah to trace a medical timeline that broke the speed limit of standard textbook guidelines. It is a story of rapid clinical pivots, genomic sequencing, and a quiet, non-invasive laser surgery where physicians played "Space Invaders" with her tumors while Deborah listened to Satie. We also bring back The Epi Edit, a recurring segment where Dr. Paynter steps outside the conversation to analyze the epidemiology and science behind the lived experience. In this episode, we explore the biology of Immune-Related Adverse Events (irAEs) and why severe immunotherapy toxicities are historically correlated with exceptionally strong tumor response rates. In this episode, we discuss: • The "In-Transit" Alert: Why a skin lesion that refuses to heal is a critical warning sign. • The Trial Experience: Why Deborah immediately agreed to be a clinical "guinea pig". • The Epi Edit: The clinical paradox of high-grade immunotherapy toxicities and long-term survival. • Gamma Knife Surgery: Demystifying non-invasive laser-guided brain surgery. • Steroid Mania: Navigating the sleepless, hyper-chatty reality of high-dose dexamethasone. • I'll Live: How Deborah used writing as a cognitive lifeline and connected with a patient in Northern Ireland. -- Go to ChangedByCancer.com for show notes, blog links, and resources Research articles & links referenced: • Deborah's Blog: I'll Live https://ill-live.com/ • Gamma Knife Overview: A patient-friendly guide explaining how focused radiation beams treat specific brain areas without incisions. https://www.mayoclinic.org/tests-procedures/brain-stereotactic-radiosurgery/about/pac-20384679 • Understanding Immunotherapy: What Is Immunotherapy? — An accessible overview of how these treatments utilize the body's own immune system to recognize and fight cancer cells. https://www.cancer.org/cancer/managing-cancer/treatment-types/immunotherapy.html • Targeted Cancer Therapies: A clear explanation of how "precision medicine" drugs are engineered to block specific proteins that allow cancer cells to grow. https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies • irAEs and Response Rates: Fan Y, et al. Association of Immune Related Adverse Events With Efficacy of Immune Checkpoint Inhibitors and Overall Survival in Cancers: A Systemic Review and Meta-analysis. Front Oncol. 2021 Apr 12;11:633032. doi: 10.3389/fonc.2021.633032. PMID: 33912454; PMCID: PMC8072154. (Frontiers in Oncology, 2021). https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2021.633032/full Changed By Cancer is hosted by Dr. Randi Paynter, a cancer epidemiologist. This podcast shares personal experiences and systemic issues in healthcare. It is not medical advice. Please consult your own medical team for health-related decisions.

  ListenShow Notes

Based on semantic analysis of episode topics and host coverage, this show is a strong guest fit for executives in:

Industry fit is computed by PitchCentric using vector embeddings of the show's episode catalog.